Aurinia Pharmaceuticals Inc (AUPH)

Cost of Revenue

$6.56M

Quarterly · Period ending: · USD

AUPH logo

AUPH Cost of Revenue

Latest reported$6.56M
AUPH Quarterly Cost of Revenue ($265.16K → $6.56M)
High-resolution chart · PNG

AUPH cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
288,955
217,617
197,574
66,740
206,745
76,910
200,729
135,640
265,164
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.